Stockscreener 앱 받기
2.45
0.41%
0.01
Invivyd Inc 주식(IVVD)의 최신 뉴스
Bull Run: What is the target price for Invivyd Inc stockMarket Volume Summary & Safe Entry Trade Reports - baoquankhu1.vn
Invivyd, Inc.'s (NASDAQ:IVVD) Business Is Trailing The Industry But Its Shares Aren't - 富途牛牛
Invivyd, Inc. (NASDAQ:IVVD) Given Average Rating of "Hold" by Brokerages - MarketBeat
Invivyd (IVVD) Reports Strong Q4 Growth, Advances COVID Antibody to Phase 3 - Insider Monkey
MINISTRY OF HOME AFFAIRS OF THE SOCIALIST REPUBLIC OF VIETNAM - Bộ Nội Vụ
Invivyd (NASDAQ:IVVD) Trading Down 6.5%Time to Sell? - MarketBeat
Invivyd granted FDA fast track status for COVID therapy - MSN
Why Analysts See Invivyd (IVVD) Story Shifting After REVOLUTION Program And US$10 Target - Yahoo Finance
Invivyd (NASDAQ:IVVD) Trading Up 10.6%What's Next? - MarketBeat
Invivyd reports 25% growth in Q4 PEMGARDA revenue to $17.2 million - Investing.com Nigeria
Will Invivyd's DECLARATION Trial Send IVVD Stock Higher In 2026? - RTTNews
Invivyd (NASDAQ:IVVD) Shares Gap UpWhat's Next? - MarketBeat
Why Invivyd Inc. stock is trending among retail traders2025 Earnings Surprises & Free Reliable Trade Execution Plans - ulpravda.ru
Invivyd Reports Strong PEMGARDA Growth and Advances VYD2311 - TipRanks
Invivyd, Inc. Reports Preliminary Q4 2025 Revenue of $17.2 Million and Announces Key Clinical Developments - Quiver Quantitative
Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights - The Manila Times
Star TribuneInvivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights - FinancialContent
Invivyd, Inc. (IVVD): Advancing RSV antibody VBY329 amid analyst downgrade - MSN
Invivyd (NASDAQ:IVVD) Stock Price Down 5.5%Here's What Happened - MarketBeat
Aug Gainers: Why Heiwa Real Estate Co Ltd HZJ stock appears on watchlistsDividend Hike & Growth Focused Entry Reports - moha.gov.vn
Invivyd Inc. | Latest News & Innovations - shababeek.org
BTIG initiates Invivyd (IVVD) coverage, cites VYD2311’s superior market potential over Pemgarda - MSN
BTIG Initiates Invivyd (IVVD) Coverage, Cites VYD2311’s Superior Market Potential Over Pemgarda - Insider Monkey
BTIG Initiates Invivyd (IVVD) Coverage, Cites VYD2311's Superior Market Potential Over Pemgarda - Finviz
Invivyd (NASDAQ:IVVD) Trading Down 3.7%Here's Why - MarketBeat
Is Invivyd Inc. stock supported by strong fundamentalsChart Pattern Recognition & Minimal Risk High Reward - bollywoodhelpline.com
Does Invivyd’s (IVVD) Index Debut Reveal a Turning Point in Its Biotech Credibility? - Yahoo Finance
BTIG Reiterates Invivyd (IVVD) Buy Recommendation - Nasdaq
BTIG Research Upgrades Invivyd (NASDAQ:IVVD) to Strong-Buy - MarketBeat
FDA grants fast track designation for Invivyd’s COVID antibody By Investing.com - Investing.com Nigeria
Invivyd begins phase 3 trial of COVID prevention antibody VYD2311 By Investing.com - Investing.com Nigeria
US OPEN: Markets wobble amid low volumes and resilient GDP (23.12.2025) - XTB.com
Is Invivyd’s (IVVD) Index Debut Quietly Reframing Its Long-Term Biotech Positioning? - simplywall.st
Invivyd wins FDA fast track tag for COVID drug (IVVD:NASDAQ) - Seeking Alpha
Invivyd Says Vaccine-Alternative Antibody to Prevent COVID Gets FDA Fast Track Designation; Phase 3 Trial Launched - marketscreener.com
Invivyd’s COVID Antibody VYD2311 Receives FDA Fast Track - TipRanks
FDA grants fast track designation for Invivyd’s COVID antibody - Investing.com India
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID - The Manila Times
Invivyd announces initiation of DECLARATION clinical trial, a phase 3 placebo-controlled pivotal study of VYD2311, a vaccine-alternative antibody to prevent Covid-19 - marketscreener.com
Invivyd stock rises after FDA grants Fast Track designation for COVID antibody - Investing.com Canada
Invivyd, Inc. Earns Fast Track Designation for COVID Antibody - TradingView — Track All Markets
Invivyd rises as drugmaker starts late-stage trial for COVID prevention antibody - TradingView — Track All Markets
Invivyd begins phase 3 trial of COVID prevention antibody VYD2311 - Investing.com
FDA puts COVID prevention shot alternative from Invivyd on Fast Track - Stock Titan
New antibody shot aims to offer vaccine-alternative protection from COVID - Stock Titan
Invivyd (IVVD): Assessing Valuation After S&P Biotechnology Select Industry Index Inclusion - Yahoo Finance
This Blacksky Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Sahm
Invivyd announces proposed public offering of common stock - MSN
4.73%
0.92%
자본화:
|
볼륨(24시간):